Cargando…
Macrophage Migration Inhibitory Factor (MIF) Plasma Concentration in Critically Ill COVID-19 Patients: A Prospective Observational Study
Mortality in critically ill coronavirus disease 2019 (COVID-19) patients is high and pharmacological treatment strategies remain limited. Early-stage predictive biomarkers are needed to identify patients with a high risk of severe clinical courses and to stratify treatment strategies. Macrophage mig...
Autores principales: | Bleilevens, Christian, Soppert, Josefin, Hoffmann, Adrian, Breuer, Thomas, Bernhagen, Jürgen, Martin, Lukas, Stiehler, Lara, Marx, Gernot, Dreher, Michael, Stoppe, Christian, Simon, Tim-Philipp |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922575/ https://www.ncbi.nlm.nih.gov/pubmed/33671433 http://dx.doi.org/10.3390/diagnostics11020332 |
Ejemplares similares
-
Soluble CD74 Reroutes MIF/CXCR4/AKT‐Mediated Survival of Cardiac Myofibroblasts to Necroptosis
por: Soppert, Josefin, et al.
Publicado: (2018) -
The Role of Macrophage Migration Inhibitory Factor in Anesthetic-Induced Myocardial Preconditioning
por: Goetzenich, Andreas, et al.
Publicado: (2014) -
Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study
por: Simon, Tim-Philipp, et al.
Publicado: (2021) -
The Macrophage Migration Inhibitory Factor (MIF) Promoter Polymorphisms (rs3063368, rs755622) Predict Acute Kidney Injury and Death after Cardiac Surgery
por: Averdunk, Luisa, et al.
Publicado: (2020) -
Involvement of the Macrophage Migration Inhibitory Factor (MIF) in Lipedema
por: Vasella, Mauro, et al.
Publicado: (2023)